Author

Yuki Kaya

Institutions: Meiji Pharmaceutical University, Kyoto Pharmaceutical University

Observed institutions: Meiji Pharmaceutical University, Kyoto Pharmaceutical University

ORCID: 0009-0003-3926-7079

Observed ORCID: 0009-0003-3926-7079

OpenAlex ID: A5005941687

Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii

2022 · Go Kamoshida, Noriteru Yamada, et al. · Microbiology Spectrum · 20

Development of a novel bacterial production system for recombinant bioactive proteins completely free from endotoxin contamination

2024 · Go Kamoshida, Daiki Yamaguchi, et al. · PNAS Nexus · 5

Deep‐Tissue In Vivo Imaging Using Bioluminescence in a Mouse Infection Model and the Path to High Sensitivity With Near‐Infrared Luminescence

2025 · Daiki Yamaguchi, Keita Oki, et al. · Microbiology and Immunology · 2

A non-antibiotic genetic selection system enables near-infrared in vivo imaging and evaluation of antibiotic efficacy for multidrug-resistant Acinetobacter baumannii

2026 · Daiki Yamaguchi, Go Kamoshida, et al. · The Journal of Antibiotics

Works count: 4

Citation count: 27

H-index: 2

I10-index: 1